On January 3, 2024, Madryn Asset Management, LP announced that Egan-Jones Proxy Services, an independent proxy advisory firm, has recommended shareholders vote against the proposed merger with Standard BioTools Inc. at the Company?s Special Meeting of Shareholders on January 4, 2024. Madryn urged shareholders to vote against the proposed merger to protect the value of shareholders? investment and allow the Company to pursue vastly superior alternatives.
Standard BioTools Inc.
Equities
SLGC
US83444K1051
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |